Publications by authors named "Helen Meadows"

Claim this Profile
W
Where do we go from here? - Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionals.
Eleanor Mitchell, Kirsteen Goodman, Suzanne Hartley, Helen Hickey, Alison M McDonald, Helen M Meadows

Trials· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC).
Eleonor Rivin Del Campo, Oscar Matzinger, Karin Haustermans, Didier Peiffert, Robert Glynne-Jones, Helen Meadows

Eur J Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical endpoints in trials of chemoradiation for patients with anal cancer.
Robert Glynne-Jones, Richard Adams, Andre Lopes, Helen Meadows

Lancet Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial.
Robert Glynne-Jones, David Sebag-Montefiore, Helen M Meadows, David Cunningham, Rubina Begum

Lancet Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End points in anal cancer: hopes for a common language.
Rob Glynne-Jones, Richard A Adams, Mark Jitlal, Helen Meadows

J Clin Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.
Roger D James, Robert Glynne-Jones, Helen M Meadows, David Cunningham, Arthur Sun Myint

Lancet Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for recurrence and survival in anal cancer: generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I).
Robert Glynne-Jones, David Sebag-Montefiore, Richard Adams, Simon Gollins, Mark Harrison, Helen M Meadows

Cancer· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and long term efficacy of porfimer sodium photodynamic therapy in locally advanced biliary tract carcinoma.
Stephen P Pereira, Guruprasad P Aithal, Krish Ragunath, John Devlin, Faye Owen, Helen Meadows

Photodiagnosis Photodyn Ther· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin.
David Sebag-Montefiore, Helen M Meadows, David Cunningham, Piers N Plowman, David C Hurman

Radiother Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Mind the gap"--the impact of variations in the duration of the treatment gap and overall treatment time in the first UK Anal Cancer Trial (ACT I).
Rob Glynne-Jones, David Sebag-Montefiore, Richard Adams, Alec McDonald, Simon Gollins, Helen M Meadows

Int J Radiat Oncol Biol Phys· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population patch-clamp electrophysiology analysis of recombinant GABAA alpha1beta3gamma2 channels expressed in HEK-293 cells.
Emma C Hollands, Tim J Dale, Andrew W Baxter, Helen J Meadows, Andrew J Powell

J Biomol Screen· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer.
Rob Glynne-Jones, Helen Meadows, Susan Wan, Simon Gollins, Martin Leslie

Int J Radiat Oncol Biol Phys· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mGlu4 potentiation of K(2P)2.1 is dependant on C-terminal dephosphorylation.
Stuart M Cain, Helen J Meadows, John Dunlop, Trevor J Bushell

Mol Cell Neurosci· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved functional expression of recombinant human ether-a-go-go (hERG) K+ channels by cultivation at reduced temperature.
Mao Xiang Chen, Shaun L Sandow, Virginie Doceul, Yu Hua Chen, Heather Harper, Helen J Meadows

BMC Biotechnol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 384-well population patch clamp electrophysiology assays for Ca2+-activated K+ channels.
Victoria H John, Tim J Dale, Emma C Hollands, Mao Xiang Chen, Leanne Partington, Helen J Meadows

J Biomol Screen· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective block of the human 2-P domain potassium channel, TASK-3, and the native leak potassium current, IKSO, by zinc.
Catherine E Clarke, Emma L Veale, Paula J Green, Helen J Meadows, Alistair Mathie

J Physiol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cloning and functional expression of a human orthologue of rat vanilloid receptor-1.
Philip Hayes, Helen J Meadows, Martin J Gunthorpe, Mark H Harries, Malcolm D Duckworth

Pain· November 2000

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis